INTERVIEW | How an unassuming acquisition is putting Aspen on the map as a Covid-19 vaccine manufacturer

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
Gus Attridge, is stepping down at the end of 2021
Gus Attridge, is stepping down at the end of 2021

In the past 24 years, Aspen Pharmacare has grown into a company valued at more than R67 billion, but a package deal on an acquisition it made in its early days has put it on the map as a Covid-19 vaccine manufacturer and has set the tone its growth.

In 1998, a year after listing on the JSE, Aspen acquired SA Druggists, which owned the Lennon brand of home remedies. The acquisition came with the Lennon factory in Port Elizabeth. 

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in
USD/ZAR
14.28
(+0.3)
GBP/ZAR
19.84
(-0.1)
EUR/ZAR
17.21
(+0.4)
AUD/ZAR
11.06
(+0.2)
JPY/ZAR
0.13
(+0.2)
Gold
1,785.93
(-0.4)
Silver
26.38
(-0.6)
Platinum
1,208.25
(-0.8)
Brent Crude
65.32
(-1.9)
Palladium
2,859.16
(-0.8)
All Share
67,000
(-0.2)
Top 40
61,215
(-0.3)
Financial 15
12,128
(+0.0)
Industrial 25
86,720
(-0.0)
Resource 10
68,752
(-0.7)
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Voting Booth
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, and I've gotten it.
21% - 1296 votes
No, I did not.
52% - 3232 votes
My landlord refused
28% - 1735 votes
Vote